We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

9 hedge funds and large institutions have $32.6M invested in IVERIC bio, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ICAP
Independence Capital Asset Partners
Colorado
+$11.5M
2
CWAM
Columbia Wanger Asset Management
Illinois
+$7.49M
3
JCG
JHL Capital Group
Illinois
+$5.39M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.7M
5
VM
VHCP Management
New York
+$1.49M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ICAP
1
Independence Capital Asset Partners
Colorado
$12.1M +$11.5M +406,248 New
CWAM
2
Columbia Wanger Asset Management
Illinois
$7.84M +$7.49M +264,000 New
JCG
3
JHL Capital Group
Illinois
$5.64M +$5.39M +190,000 New
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$1.78M +$1.7M +60,000 New
VM
5
VHCP Management
New York
$1.56M +$1.49M +52,500 New
EEG
6
E.E. Geduld
$1.51M +$1.44M +50,917 New
Citadel Advisors
7
Citadel Advisors
Florida
$1.16M +$1.11M +39,106 New
MCM
8
Mazama Capital Management
Oregon
$594K +$567K +20,000 New
Ameriprise
9
Ameriprise
Minnesota
$386K +$369K +13,000 New

ISEE Hedge Fund Activity: Q3 2013 in Review

9 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2013, worth a combined $32.6M.

Buyers outnumbered sellers: 9 funds opened new ISEE positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Independence Capital Asset Partners, opening a new position worth an estimated $11.5M.

  • 9 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $32.6M of IVERIC bio, Inc. Common Stock stock for Q3 2013.
  • 9 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2013 and 0 closed out, a net change of +9 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2013 was Independence Capital Asset Partners, an estimated $11.5M added.

Based on aggregated 13F filings for Q3 2013.